Prognostic factors and historical trends in the epidemiology of candidemia in critically ill patients: an analysis of five multicenter studies sequentially conducted over a 9-year period

Intensive Care Medicine

Volumn 40, Issue 10, 2014, Pages 1489-1498

  Colombo, Arnaldo L ^a,g   Guimarães, Thais ^b   Sukienik, Teresa ^c   Pasqualotto, Alessandro C ^d   Andreotti, Ricardo ^a   Queiroz Telles, Flavio ^e   Nouér, Simone A ^f   Nucci, Marcio ^f  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b HOSPITAL DO SERVIDOR PÚBLICO ESTADUAL DE SÃO PAULO   (Brazil)

^c Irmandade da Santa Casa de Misericordia de Porto Alegre   (Brazil)

^d UNIVERSIDADE FEDERAL DE CIÊNCIAS DA SAÚDE DE PORTO ALEGRE   (Brazil)

^e FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^f FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^g NONE   (Brazil)

Author keywords

Antifungal therapy; Candidemia; Echinocandin; Invasive candidiasis; Mortality

Indexed keywords

AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; ANTIBIOTIC AGENT; CORTICOSTEROID; ECHINOCANDIN; FLUCONAZOLE; IMMUNOSUPPRESSIVE AGENT; ANTIFUNGAL AGENT; CHOLAGOGUE; DEOXYCHOLIC ACID;

ADULT; AGED; APACHE; ARTICLE; ARTIFICIAL VENTILATION; AUTOIMMUNE DISEASE; BLOOD CULTURE; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CANDIDEMIA; CENTRAL VENOUS CATHETERIZATION; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CRITICALLY ILL PATIENT; DIALYSIS; DRUG EXPOSURE; EPIDEMIOLOGICAL MONITORING; FEMALE; FUNGUS IDENTIFICATION; HISTORY; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MORTALITY; MULTICENTER STUDY (TOPIC); NONHUMAN; ORGAN TRANSPLANTATION; OUTCOME ASSESSMENT; PRIVATE HOSPITAL; PROGNOSIS; PUBLIC HOSPITAL; RETROSPECTIVE STUDY; SENESCENCE; SPECIES DISTRIBUTION; SURGERY; SURVIVAL; ADOLESCENT; BRAZIL; CRITICAL ILLNESS; MIDDLE AGED; MULTIVARIATE ANALYSIS; STATISTICS AND NUMERICAL DATA; TERTIARY CARE CENTER; TRENDS; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIFUNGAL AGENTS; BRAZIL; CANDIDEMIA; CHOLAGOGUES AND CHOLERETICS; CRITICAL ILLNESS; DEOXYCHOLIC ACID; ECHINOCANDINS; FEMALE; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; MULTICENTER STUDIES AS TOPIC; MULTIVARIATE ANALYSIS; PROGNOSIS; RETROSPECTIVE STUDIES; TERTIARY CARE CENTERS; YOUNG ADULT;

EID: 84919390584     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/s00134-014-3400-y     Document Type: Article

References (32)

1. Delaloye J, Calandra T (2014) Invasive candidiasis as a cause of sepsis in the critically ill patient. Virulence 5:161–169. doi:10.4161/viru.26187
2. Bassetti M, Righi E, Ansaldi F, Merelli M, Cecilia T, De Pascale G, Diaz-Martin A, Luzzati R, Rison C, Lagunes L, Trecarichi EM, Sanguinetti M, Posteraro B, Garnacho-Montero J, Sartor A, Rello J, Rocca GD, Antoneiil M, Tumbarello M (2014) A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality. Intensive Care Med 40:839–845. doi:10.1007/s00134-014-3310-z
3. Leon C, Ostrosky-Zeichner L, Schuster M (2014) What’s new in the clinical and diagnostic management of invasive candidiasis in critically ill patients. Intensive Care Med 40:808–819. doi:10.1007/s00134-014-3281-0
4. Asmundsdottir LR, Erlendsdottir H, Gottfredsson M (2013) Nationwide study of candidemia, antifungal use, and antifungal drug resistance in Iceland, 2000–2011. J Clin Microbiol 51:841–848. doi:10.1128/JCM.02566-12
5. Cleveland AA, Farley MM, Harrison LH, Stein B, Hollick R, Lockhart SR, Magill SS, Derado G, Park BJ, Chiller TM (2012) Changes in incidence and antifungal drug resistance in candidemia: results from population-based laboratory surveillance in Atlanta and Baltimore, 2008-2011. Clin Infect Dis 55:1352–1361. doi:10.1093/cid/cis697
6. Playford EG, Nimmo GR, Tilse M, Sorrell TC (2010) Increasing incidence of candidaemia: long-term epidemiological trends, Queensland, Australia, 1999–2008. J Hosp Infect 76:46–51. doi:10.1016/j.jhin.2010.01.022
7. Garey KW, Rege M, Pai MP, Mingo DE, Suda KJ, Turpin RS, Bearden DT (2006) Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study. Clin Infect Dis 43:25–31. doi:10.1086/504810
8. Morrell M, Fraser VJ, Kollef MH (2005) Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob Agents Chemother 49:3640–3645. doi:10.1128/AAC.49.9.3640-3645.2005
9. Ostrosky-Zeichner L, Kullberg BJ, Bow EJ, Hadley S, Leon C, Nucci M, Patterson TF, Perfect JR (2011) Early treatment of candidemia in adults: a review. Med Mycol 49:113–120. doi:10.3109/13693786.2010.512300
10. Leon C, Ruiz-Santana S, Saavedra P, Galvan B, Blanco A, Castro C, Balasini C, Utande-Vazquez A, Gonzalez de Molina FJ, Blasco-Navalproto MA, Lopez MJ, Charles PE, Martin E, Hernandez-Viera MA (2009) Usefulness of the “Candida score” for discriminating between Candida colonization and invasive candidiasis in non-neutropenic critically ill patients: a prospective multicenter study. Crit Care Med 37:1624–1633. doi:10.1097/CCM.0b013e31819daa14
11. Bassetti M, Marchetti M, Chakrabarti A, Colizza S, Garnacho-Montero J, Kett DH, Munoz P, Cristini F, Andoniadou A, Viale P, Rocca GD, Roilides E, Sganga G, Walsh TJ, Tascini C, Tumbarello M, Menichetti F, Righi E, Eckmann C, Viscoli C, Shorr AF, Leroy O, Petrikos G, De Rosa FG (2013) A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts. Intensive Care Med 39:2092–2106. doi:10.1007/s00134-013-3109-3
12. Leon C, Ruiz-Santana S, Saavedra P, Castro C, Ubeda A, Loza A, Martin-Mazuelos E, Blanco A, Jerez V, Ballus J, Alvarez-Rocha L, Utande-Vazquez A, Farinas O (2012) Value of beta-d-glucan and Candida albicans germ tube antibody for discriminating between Candida colonization and invasive candidiasis in patients with severe abdominal conditions. Intensive Care Med 38:1315–1325. doi:10.1007/s00134-012-2616-y
13. Colombo AL, Thompson L, Graybill JR (2008) The north and south of candidemia: issues for Latin America. Drugs Today (Barc) 44[Suppl A]:1–34
14. Nucci M, Queiroz-Telles F, Alvarado-Matute T, Tiraboschi IN, Cortes J, Zurita J, Guzman-Blanco M, Santolaya ME, Thompson L, Sifuentes-Osornio J, Echevarria JI, Colombo AL (2013) Epidemiology of candidemia in Latin America: a laboratory-based survey. PLoS ONE 8:e59373. doi:10.1371/journal.pone.0059373
15. Santolaya ME, Alvarado T, Queiroz-Telles F, Colombo AL, Zurita J, Tiraboschi IN, Cortes JA, Thompson L, Guzman M, Sifuentes J, Echevarria JI, Nucci M (2014) Active surveillance of candidemia in children from Latin America: a key requirement for improving disease outcome. Pediatr Infect Dis J 33:e40–e44. doi:10.1097/INF.0000000000000039
16. Garnacho-Montero J, Diaz-Martin A, Garcia-Cabrera E, de Ruiz Perez PM, Hernandez-Caballero C, Aznar-Martin J, Cisneros JM, Ortiz-Leyba C (2010) Risk factors for fluconazole-resistant candidemia. Antimicrob Agents Chemother 54:3149–3154. doi:10.1128/AAC.00479-10
17. Slavin MA, Sorrell TC, Marriott D, Thursky KA, Nguyen Q, Ellis DH, Morrissey CO, Chen SC (2010) Candidaemia in adult cancer patients: risks for fluconazole-resistant isolates and death. J Antimicrob Chemother 65:1042–1051. doi:10.1093/jac/dkq053
18. Diekema D, Arbefeville S, Boyken L, Kroeger J, Pfaller M (2012) The changing epidemiology of healthcare-associated candidemia over three decades. Diagn Microbiol Infect Dis 73:45–48. doi:10.1016/j.diagmicrobio.2012.02.001
19. Lortholary O, Desnos-Ollivier M, Sitbon K, Fontanet A, Bretagne S, Dromer F (2011) Recent exposure to caspofungin or fluconazole influences the epidemiology of candidemia: a prospective multicenter study involving 2,441 patients. Antimicrob Agents Chemother 55:532–538. doi:10.1128/AAC.01128-10
20. Colombo AL, Garnica M, Aranha Camargo LF, Da Cunha CA, Bandeira AC, Borghi D, Campos T, Senna AL, Valias Didier ME, Dias VC, Nucci M (2013) Candida glabrata: an emerging pathogen in Brazilian tertiary care hospitals. Med Mycol 51:38–44. doi:10.3109/13693786.2012.698024
21. Moretti ML, Trabasso P, Lyra L, Fagnani R, Resende MR, de Oliveira Cardoso LG, Schreiber AZ (2013) Is the incidence of candidemia caused by Candida glabrata increasing in Brazil? Five-year surveillance of Candida bloodstream infection in a university reference hospital in southeast Brazil. Med Mycol 51:225–230. doi:10.3109/13693786.2012.708107
22. Pasqualotto AC, Zimerman RA, Alves SH, Aquino VR, Branco D, Wiltgen D, do AA, Cechinel R, Colares SM, Rocha IG, Severo LC, Sukiennik TC (2008) Take control over your fluconazole prescriptions: the growing importance of Candida glabrata as an agent of candidemia in Brazil. Infect Control Hosp Epidemiol 29:898–899. doi:10.1086/590191
23. Kett DH, Azoulay E, Echeverria PM, Vincent JL (2011) Candida bloodstream infections in intensive care units: analysis of the extended prevalence of infection in intensive care unit study. Crit Care Med 39:665–670. doi:10.1097/CCM.0b013e318206c1ca
24. Bassetti M, Taramasso L, Nicco E, Molinari MP, Mussap M, Viscoli C (2011) Epidemiology, species distribution, antifungal susceptibility and outcome of nosocomial candidemia in a tertiary care hospital in Italy. PLoS ONE 6:e24198. doi:10.1371/journal.pone.0024198
25. Puig-Asensio M, Peman J, Zaragoza R, Garnacho-Montero J, Martin-Mazuelos E, Cuenca-Estrella M, Almirante B (2014) Impact of therapeutic strategies on the prognosis of candidemia in the ICU. Crit Care Med 42:1423–1432. doi: 10.1097/CCM.0000000000000221
26. Reboli AC, Rotstein C, Pappas PG, Chapman SW, Kett DH, Kumar D, Betts R, Wible M, Goldstein BP, Schranz J, Krause DS, Walsh TJ (2007) Anidulafungin versus fluconazole for invasive candidiasis. N Engl J Med 356:2472–2482. doi:10.1056/NEJMoa066906
27. Andes DR, Safdar N, Baddley JW, Playford G, Reboli AC, Rex JH, Sobel JD, Pappas PG, Kullberg BJ (2012) Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials. Clin Infect Dis 54:1110–1122. doi:10.1093/cid/cis021
28. Leroy O, Gangneux JP, Montravers P, Mira JP, Gouin F, Sollet JP, Carlet J, Reynes J, Rosenheim M, Regnier B, Lortholary O (2009) Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006). Crit Care Med 37:1612–1618. doi:10.1097/CCM.0b013e31819efac0
29. Marriott DJ, Playford EG, Chen S, Slavin M, Nguyen Q, Ellis D, Sorrell TC (2009) Determinants of mortality in non-neutropenic ICU patients with candidaemia. Crit Care 13:R115. doi:10.1186/cc7964
30. Munoz P, Giannella M, Fanciulli C, Guinea J, Valerio M, Rojas L, Rodriguez-Creixems M, Bouza E (2011) Candida tropicalis fungaemia: incidence, risk factors and mortality in a general hospital. Clin Microbiol Infect 17:1538–1545. doi:10.1111/j.1469-0691.2010.03338.x
31. Tortorano AM, Biraghi E, Astolfi A, Ossi C, Tejada M, Farina C, Perin S, Bonaccorso C, Cavanna C, Raballo A, Grossi A (2002) European Confederation of Medical Mycology (ECMM) prospective survey of candidaemia: report from one Italian region. J Hosp Infect 51:297–304. doi:10.1053/jhin.2002.1261
32. Nucci M, Anaissie E, Betts RF, Dupont BF, Wu C, Buell DN, Kovanda L, Lortholary O (2010) Early removal of central venous catheter in patients with candidemia does not improve outcome: analysis of 842 patients from 2 randomized clinical trials. Clin Infect Dis 51:295–303. doi:10.1086/653935